HomeLiothyronine SodiumLiothyronine Sodium + Phenytoin

Does Liothyronine Sodium Interact with Phenytoin?

Liothyronine Sodium and Phenytoin have a moderate drug interaction according to U.S. FDA drug labeling data. Reduces serum protein binding of thyroid hormones, with total and FT4 potentially reduced by 20-40%, requiring thyroid hormone monitoring. The mechanism involves reducing serum protein binding of thyroid hormones. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Phenytoin Class
Anti-epileptic Agent
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Liothyronine Sodium and Phenytoin occurs because reducing serum protein binding of thyroid hormones. Clinically, this means reduces serum protein binding of thyroid hormones, with total and ft4 potentially reduced by 20-40%, requiring thyroid hormone monitoring. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Liothyronine Sodium and your doctor is considering prescribing Phenytoin (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Liothyronine Sodium(Liothyronine Sodium)+💊 Phenytoin(Phenytoin Infatabs)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Anti-epileptic Agent
Source
NLP:liothyronine sodium

What this means in plain English

Reduces serum protein binding of thyroid hormones, with total and FT4 potentially reduced by 20-40%, requiring thyroid hormone monitoring.

What the FDA label says

"Reducing serum protein binding of thyroid hormones"

📖 Source: NLP:liothyronine sodium

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Liothyronine Sodium and Phenytoin against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.